Form 4: Guardant Health Director Acquires Shares via RSU Vesting

Guardant Health Director Manuel Hidalgo Medina acquired 232 shares of common stock through the vesting of restricted stock units.

Summary

• Manuel Hidalgo Medina, a Director of Guardant Health, Inc. (GH), acquired 232 shares of common stock.
• The acquisition occurred on September 17, 2025, through the vesting of Restricted Stock Units (RSUs).
• The transaction price for the acquired common stock was $0, as it represents a vesting event.
• Following this transaction, Manuel Hidalgo Medina directly owns 1,083 shares of Guardant Health common stock.
• Additionally, Manuel Hidalgo Medina directly holds 7,889 Restricted Stock Units.
• The RSU award was granted on July 17, 2024, with 25% vesting on the one-year anniversary of the grant date, and the remaining 75% vesting monthly over the subsequent three-year period.

Sentiment

Score: 6

Explanation: The transaction is a routine vesting of restricted stock units, increasing a director's direct ownership in the company, which is generally viewed as a neutral to slightly positive signal of alignment.

Positives

• Increased direct ownership by a director, aligning management interests with shareholders.
• The transaction is a routine vesting event, indicating stability in executive compensation and equity plans.

Future Outlook

This filing does not contain forward-looking statements or guidance, as it is a report of an insider transaction.

Industry Context

This is a routine insider transaction report and does not provide information related to broader industry trends or competitors.

Stakeholder Impact

• Shareholders: The transaction indicates continued alignment of a director's interests with shareholders through increased direct stock ownership.

Key Dates

Recommendation

This Form 4 reports a routine vesting of restricted stock units for a director, which is a standard compensation event and does not provide new material information to alter an investment thesis. It indicates continued insider ownership but is not a significant catalyst for a 'buy' or 'sell' recommendation.

Keywords

Guardant Health, GH, Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Director Stock Acquisition, Manuel Hidalgo Medina